Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000335532 | SCV000335938 | benign | not specified | 2015-10-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000335532 | SCV000613062 | benign | not specified | 2016-12-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000556875 | SCV000650621 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2P; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000190546 | SCV001136527 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2P | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001723761 | SCV001950467 | benign | not provided | 2018-12-11 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25503980, 29036200, 31180159) |
Fulgent Genetics, |
RCV000556875 | SCV002795432 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2P; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001723761 | SCV004147393 | benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | DAG1: BS1, BS2 |
Breakthrough Genomics, |
RCV001723761 | SCV005303480 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000190546 | SCV000245427 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2P | 2015-01-20 | no assertion criteria provided | literature only | |
Prevention |
RCV003907668 | SCV004727350 | likely benign | DAG1-related disorder | 2019-11-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |